Deal Intelligence Platform & Services for Global M&A / PE
2021 brought a flurry of #MnA activity in the life sciences sector, followed by a slowdown in 2022. Here’s why dealmaking could pick up again. deloi.tt/3PIOHZP
– Deloitte M&A (@DeloitteMnA)09:00 – Aug 31, 2022
Viatris Inc. agreed to purchase Pacira BioSciences Inc. for $36.50 per share in cash on October 8, 2026, establishing an equity valuation of approximately $1.65 billion. The transaction establishes...
Shionogi & Co., Ltd. agreed to acquire IntraBio Inc. for $2.0 billion in an all-cash transaction announced on October 5, 2026. The Japanese pharmaceutical company will purchase 100 percent of the...
GE HealthCare announced on October 5, 2026, that it agreed to purchase SOFIE Biosciences from private equity firm Trilantic North America for $945 million in cash. SOFIE Biosciences operates as a...
Spire Healthcare Group agreed on September 5, 2026, to a £1.03 billion cash takeover by Tulip UK Bidco, an investment consortium led by hedge fund manager Toscafund Asset Management alongside THCP...